HER2 Support Group Forums - View Single Post - Phase 1 Anti-HER-2 Vaccine (APC8024) Shows Clinical Benefit

06-02-2003, 09:51 AM

Dendreon's Phase I Results of APC8024 -- anti-HER-2 Therapeutic Vaccine Demonstrate Ongoing Clinical Benefit in Women with Advanced Metastatic Breast Cancer as reported at the American Society of Clinical Oncology 2003 Annual Meeting

06-02-2003, 09:51 AM	#1
Paul Guest Posts: n/a	Dendreon's Phase I Results of APC8024 -- anti-HER-2 Therapeutic Vaccine Demonstrate Ongoing Clinical Benefit in Women with Advanced Metastatic Breast Cancer as reported at the American Society of Clinical Oncology 2003 Annual Meeting